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Abstract
Background: Achilles tendinopathy is the predominant overuse injury in runners. To further
investigate this overload injury in transverse and longitudinal studies a valid, responsive and reliable
outcome measure is demanded. Most questionnaires have been developed for English-speaking
populations. This is also true for the VISA-A score, so far representing the only valid, reliable, and
disease specific questionnaire for Achilles tendinopathy. To internationally compare research
results, to perform multinational studies or to exclude bias originating from subpopulations
speaking different languages within one country an equivalent instrument is demanded in different
languages. The aim of this study was therefore to cross-cultural adapt and validate the VISA-A
questionnaire for German-speaking Achilles tendinopathy patients.
Methods: According to the "guidelines for the process of cross-cultural adaptation of self-report
measures" the VISA-A score was cross-culturally adapted into German (VISA-A-G) using six steps:
Translation, synthesis, back translation, expert committee review, pretesting (n = 77), and appraisal
of the adaptation process by an advisory committee determining the adequacy of the cross-cultural
adaptation. The resulting VISA-A-G was then subjected to an analysis of reliability, validity, and
internal consistency in 30 Achilles tendinopathy patients and 79 asymptomatic people. Concurrent
validity was tested against a generic tendon grading system (Percy and Conochie) and against a
classification system for the effect of pain on athletic performance (Curwin and Stanish).
Results: The "advisory committee" determined the VISA-A-G questionnaire as been translated
"acceptable". The VISA-A-G questionnaire showed moderate to excellent test-retest reliability
(ICC = 0.60 to 0.97). Concurrent validity showed good coherence when correlated with the
grading system of Curwin and Stanish (rho = -0.95) and for the Percy and Conochie grade of
severity (rho 0.95). Internal consistency (Cronbach's alpha) for the total VISA-A-G scores of the
patients was calculated to be 0.737.
Conclusion: The VISA-A questionnaire was successfully cross-cultural adapted and validated for
use in German speaking populations. The psychometric properties of the VISA-A-G questionnaire
are similar to those of the original English version. It therefore can be recommended as a sufficiently
robust tool for future measuring clinical severity of Achilles tendinopathy in German speaking
patients.
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Background
Achilles tendinopathy is the most common differential
diagnosis of posterior heel pain [1-4]. Achilles tendinopa-
thy is the predominant overuse injury in runners with a
prevalence of 10% [5] and an incidence of 0.01/1000 km
[6].
The worth of conservative and operative treatment
options is still under debate [7]. To further investigate
these issues in transverse and longitudinal studies a valid,
responsive, and reliable outcome measure is demanded.
For this reason an international group of experts from the
Victorian Institute of Sports Assessment developed the
VISA-A (the second A stands for "Achilles tendon") ques-
tionnaire [8].
"The VISA-A is an easily self-administered questionnaire
that evaluates symptoms and their effect on physical activ-
ity. It can be used to compare different populations with
Achilles tendinopathy, and facilitate comparisons
between studies. It can be used to determine the patient's
clinical severity and provide a guideline for treatment as
well as for monitoring the effect of treatment [9]." Pain
(questions 1-3), function (questions 4-6), and activity
(questions 7 and 8) are the domains under consideration
[8]. Maximum score of each item one to seven is 10, while
question 8 yields a maximum of 30. Consequently a
summed maximum score of 100 represents an asympto-
matic person [8].
The VISA-A questionnaire represents the only valid, relia-
ble, and disease specific score to measure the condition of
the Achilles tendon. Meanwhile it achieved wide accept-
ance [9-16]. However, as most questionnaires it has been
developed for an English-speaking population. To inter-
nationally compare research results, to perform multina-
tional studies or to minimize bias originating from
subpopulations speaking different languages within one
country a unique protocol of forward and back transla-
tions and cultural adaptations as well as "verification of
the scaling requirements (item performance, item
weights) and validation of and establishing normative
values for the new version" are required [17]. This proce-
dure has already been performed and is published for the
Swedish [9] and Italian [12] version of the VISA-A ques-
tionnaire. Cross-cultural adaptations to Spanish, Portu-
guese, and Flemish language have been done (Karim
Khan personal communication, 2009) but were not
reported in journals available in Medline/PubMed. The
aim of this study was therefore to cross-culturally adapt
and validate the VISA-A questionnaire for German-speak-
ing Achilles tendinopathy patients.
Methods
The study was approved by the local ethics committee.
According to the "guidelines for the process of cross-cul-
tural adaptation of self-report measures" the VISA-A score
was cross-culturally adapted into German (VISA-A-G) in
six steps [17].
Step I: Initial translation from English to German (for-
ward translation) was performed by three independent
translators with German mother tongue. An orthopaedic
surgeon specialised in foot, ankle, and Achilles tendon,
and a sport scientist both were aware of the concepts
being examined in the questionnaire. A third translator
without medical background ("naïve translator") was not
familiar with the questionnaire's concepts. Written
reports were made to indicate rationales for decision mak-
ing, linguistic difficulties and problems with regards to
content.
Step II: Considering the original VISA-A the resulting three
German versions were synthesized during a consensus
meeting of the three translators. A written report docu-
mented the procedure.
Step III: Back translation of the preliminarily VISA-A-G
questionnaire was then conducted by two American Eng-
lish native speakers fluid in German but without medical
background and blind to the original VISA-A.
Step IV: An expert committee was constituted including
forward and back translators, a health professional, and a
language professional. This panel developed the prefinal
VISA-A-G version by consensus discussion with respect to
semantic, idiomatic, experiential, and conceptual equiva-
lence based on all previous material (original, target and
back translated questionnaires including the respective
reports).
Step V (pretesting): The prefinal questionnaire was filled
out by a cohort of 35 male and 42 female persons (asymp-
tomatic persons). These persons were then asked regard-
ing their individual understanding of the questionnaire's
items. The interviewer prepared a report on the test sub-
jects, understanding of the items, and their decision mak-
ing. Again the questionnaire was adapted respectively
resulting in a final version.
Step VI: The final version of the VISA-A-G questionnaire
and all reports and forms were then subjected to a review
done by the developers of the VISA-A-G questionnaire for
appraisal of the adaptation process.
The final VISA-A-G questionnaire was then subjected to
psychometric testing including an analysis of reliability
and validity in 30 Achilles tendinopathy patients and 79
asymptomatic people. Internal consistency was evaluated
in 30 Achilles tendinopathy patients.BMC Musculoskeletal Disorders 2009, 10:134 http://www.biomedcentral.com/1471-2474/10/134
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This was done following closely the procedure described
in the original VISA-A report [8].
Test subjects: For reliability and validity testing four
groups of test subjects were defined according to the status
of their Achilles tendon. Group I included 15 preoperative
Achilles tendinopathy patients selected prospectively
from the own center. Group II consisted of 15 Achilles
tendinopathy patients conservatively treated. These
patients were recruited from review of the most recent
charts in our sports medicine center. 48 Frankfurt/Main
university pharmacology students (one class preparing for
their examinations) without Achilles tendon complaints
constituted group III. Group IV was formed by 31 mem-
bers of three local running clubs serving as non injured
but active controls. That population was recruited by
direct contact during their practise.
Inclusion criteria for all four groups were: age over 18
years, willingness to take part in this project, and ability to
give written informed consent. Contrasting to the original
VISA-A publication [8] only patients suffering from uni-
lateral Achilles tendinopathy were included (group I and
II). Achilles tendinopathy was defined as tenderness of the
midportion of the Achilles tendon 2 to 7 cm proximal to
the Achilles tendon insertion and a history of load
induced pain in this area [2-4]. This clinical diagnosis
includes degenerative Achilles tendon lesions, Achilles
tendon partial tears on a microscopic level, and paratend-
inosis or combinations of these. For the control groups
(group III and VI) subjects with previous Achilles tendon
injuries were included, if they did not complain any actual
symptoms or functional deficiencies. Persons with inade-
quate compliance and pregnant or nursing women were
excluded from participating in any of the four groups.
Patients (group I and II) with bilateral symptoms, subto-
tal or complete Achilles tendon tears, insertional Achilles
tendinopathy, Haglund's disease, and relevant injuries or
previous surgery of the lower extremity, radicular and
pseudoradicular induced pain were excluded.
To document the individual level of activity the ankle
activity score which is a reliable, valid, and sensitive meas-
ure [18] was calculated for all test subjects.
For concurrent validity testing all participants (n = 109)
completed the VISA-A-G questionnaire and Achilles tend-
inopathy severity was additionally rated by an orthopae-
dic surgeon specialized in Achilles tendon disorders (HL)
using a generic tendon grading system [19] and a "classi-
fication system for the effect of pain on athletic perform-
ance" [20]. Even if the clinimetric properties of these tools
are not formally validated so far they have been used as a
standard for concurrent validity testing in previous VISA-
A validation research [8,9,12]. Percy and Conochie cate-
gorized pain and function following surgery of Achilles
tendon tears: "Excellent" means full function and no
residual disability. "Good" is defined as full function with
no real limitation of activities and minor pain. A "fair"
result is represented by some limitation of activities.
Severe weakness and marked limping indicates a "poor"
result [19]. Curwin and Stanish assessed six degrees of
reported exercise induced tendon pain and the level of
sports performance: 1 = no pain and unrestricted level of
sports performance; 2 = pain only with extreme exertion
and unrestricted level of sports performance; 3 = pain with
extreme exertion and 1 to 2 hours afterward and normal
or slightly decreased level of sports performance; 4 = pain
during and after any vigorous activities and somewhat
decreased level of sports performance; 5 = pain during
activity forcing termination and markedly decreased level
of sports performance; 6 = pain during daily activities and
unable to perform sport [20].
Besides this, VISA-A-G results for patients expected to
present moderate symptoms (group II) and patients prob-
ably suffering the most severe symptoms (group I) were
compared with the controls (group III and IV).
Next, the VISA-A-G ratings from this study were compared
with the respective VISA-A group values presented in the
original publication [8].
For reliability testing a subset of subjects were included.
For test retest reliability all conservative patients (n = 15),
all students (n = 48), and all joggers (n = 31) were evalu-
ated by the VISA-A-G questionnaire two times within one
week. Intertester reliability was assessed by comparing the
results when both authors administered the VISA-A-G
questionnaire independently in a one to seven days inter-
val to five participants from the students and conservative
Achilles tendinopathy group respectively.
Statistical analysis
Statistics were performed using descriptive data analysis as
mean, standard deviation and 95% confidence interval.
The Kolmogorov-Smirnov test was applied to check out
for normal distribution. Concurrent validity was calcu-
lated by Spearman's rank correlation coefficient between
the VISA-A-G scores and the two standard scoring scales
[19,20]. Comparison of the VISA-A-G group scores with
the originial VISA-A [8] was performed using a two sam-
ple t-test since only means and standard deviations were
available from the original report. Reliability testing was
done by Spearman's rho, Inter-Class Correlation Coeffi-
cient (ICC) and Wilcoxon paired test for nonparametric
data. Internal consistency for the total score was calcu-
lated using Cronbach's alpha. Significance level was set at
p < 0.05.BMC Musculoskeletal Disorders 2009, 10:134 http://www.biomedcentral.com/1471-2474/10/134
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Results
Cross-cultural adaptation of the VISA-A to the VISA-A-G 
questionnaire
With regards to content one of the forward translators had
troubles to understand the meaning of the predetermined
different answers and scorings to question 8 ("If you have
no pain while undertaking Achilles tendon loading sports,
for how long can you train/practise?"): If someone would
have no sport related Achilles tendon pain, (s)he will be
able to train as long as (s)he likes. Considering this, all
persons free of Achilles tendon pain would consequently
be expected to score 30 points. In this sense this question
seemed to be irrelevant for patients suffering from Achil-
les tendinopathy. We discussed this problem with the
developers of the original VISA-A questionnaire by E-mail
who cleared this issue: if someone is just recovering from
Achilles tendinopathy, (s)he may be on reduced training
at first, say 15 minutes necessitating further answer cate-
gories (Karim Khan personal communication, 2009).
Besides this there were no relevant problems reported
from the three forward and also from the back translators
and minor linguistic discrepancies could easily be
resolved in the consensus and expert committee meeting
respectively. Prefinal VISA-A-G questionnaire testing
revealed some difficulties in comprehension of the ques-
tions 1 and 6. According to the Swedish translation [16]
the boxes were marked with the related minutes/times to
complete the final VISA-A-G version. Finally the develop-
ers approved the VISA-A-G questionnaire [see Additional
file 1] and the cross-cultural adaptation process.
VISA-A-G test population
The tested groups were not homogeneous comparing age
(Table 1). Asymptomatic students (Group III) were signif-
icantly younger than the subjects in the three other groups
(each p < 0.001) and preoperative patients were older
than the joggers group (p = 0.032). The ankle activity
mean score did not differ significantly (p = 0.733 to
0.999) between the four test groups (Table 1). Achilles
tendinopathy severity as measured with the generic ten-
don grading system [19] and the "classification system for
the effect of pain on athletic performance" [20] did not
differ comparing the preoperative with the conservative
patients, the students, and the joggers group respectively
(each p = 0.000). There was no difference found between
the jogger's and the student's groups (p = 0.864 and
0.998; Table 1).
VISA-A-G score results
Related to controls (group III and IV) VISA-A-G scores for
patients (group I and II) were significantly lower (p =
0.000). VISA-A-G questionnaire outcome was not differ-
ent comparing the asymptomatic control groups III with
IV (p = 0.347) while the symptomatic groups I with II dif-
fered significantly (p = 0.000). The preoperative and the
conservative group each were significantly different from
both control groups (each p = 0.000 Table 1, Figure 1).
Validity testing
Comparing the VISA-A-G ratings from this study with the
respective VISA-A group values presented in the original
publication [8] revealed no significant differences com-
paring the healthy and the preoperative patient groups.
Comparison between the "conservative" groups just
reached the significance level (Table 2).
The VISA-A-G questionnaire correlated significantly with
both tendon grading systems (concurrent validity). For
Table 1: Age, outcome of the VISA-A-G, Ankle Activity Score [18] Achilles tendinopathy severity as measured with a generic tendon 
grading system [19] and the "classification system for the effect of pain on athletic performance"[20] for the study population. 
Age [years] VISA-A-G Score Ankle Activity Score 
[18]
Percy & Conochie 
Score [19]
Curwin & Stanish 
Score [20]
Mean SD 95% 
CI
Mean SD 95% 
CI
Mean SD 95% 
CI
Mean SD 95% CI Mean SD 95% 
CI
Preoper
ative 
Patients
47,8 11,4 41,5-
54,1
44,9 14,2 37,0-
52,7
4,6 1,5 3,8-5,4 1,5 0,5 1,2-1,8 5,3 0,7 4,9-5,7
Conser
vative 
Patients
44,6 14,0 36,9-
52,4
73,1 13,5 65,6-
80,5
5,2 1,6 4,3-6,1 2,3 0,8 1,8-2,7 3,3 1,2 2,7-4,0
Student
s
21,0 3,9 20,0-
22,1
98,0 7,1 95,9-
100,0
4,9 2,1 4,3-5,5 3,8 0,4 3,7-4,0 1,2 0,7 1,0-1,4
Joggers 39,3 11,7 35,0-
43,6
99,2 2,0 98,5-
99,9
4,7 0,5 4,5-4,9 3,7 0,5 3,6-3,9 1,3 0,4 1,1-1,4
SD = standard deviation; CI = 95% confidence interval.BMC Musculoskeletal Disorders 2009, 10:134 http://www.biomedcentral.com/1471-2474/10/134
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the Percy and Conochie tendon classification [19] Spear-
man's rho was 0.95 (p = 0.000; Figure 2). Spearman's rho
was determined to be         -0.95 (p = 0.000) when VISA-
A-G questionnaire and the "classification system for the
effect of pain on athletic performance" [20] were com-
pared (Figure 3).
Reliability testing
Reliability testing revealed no relevant difference when
subsets of participants of the study were evaluated by the
VISA-A-G questionnaire two times within one week (ICC
= 0.60 to 0.97; Table 3). This was also true for reliability
analysis of the individual test items 1, 2, 3, 4, 5, 7 and 8
(ICC = 0.65 to 0.89; Table 4). For question 6 ICC was 0.44
(p = 0.159). Interobserver agreement was excellent (n =
10; Pearson r = 0.97, p = 0.000; ICC = 0.99, p = 0.000).
Discussion
Results of self-administered questionnaires in "popula-
tions divided by language or by culture" may systemati-
cally be biased if not equivalent in the original and target
Bar chart demonstrating the VISA-A-G mean scores (plus standard deviation) in relation to the tested groups Figure 1
Bar chart demonstrating the VISA-A-G mean scores (plus standard deviation) in relation to the tested groups.
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Table 2: Results of VISA-A-G ratings from the present study compared with the original English publication [8].
Present study
Healthy Patients
Students
98 ± 7
Joggers
99 ± 2
Conservatives
73 ± 142
Preoperatives
45 ± 14
n4 8 3 1 1 5 1 5
Robinson
et al.[]
Healthy
96 ± 7
63 0.138
Joggers
98 ± 3
20 0.198
Conservatives
64 ± 17
45 0.050
Preoperatives
44 ± 28
14 0.905BMC Musculoskeletal Disorders 2009, 10:134 http://www.biomedcentral.com/1471-2474/10/134
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version [17]. Therefore it was necessary to adapt the VISA-
A score also to a German version.
The most important finding of the present study is that the
VISA-A score was successfully adapted to a German ver-
sion and this is introduced. Reliability and validity have
been tested showing moderate to excellent results.
Systematic stepwise translation and cross-cultural adapta-
tion of the VISA-A questionnaire into a German version
(VISA-A-G) was successfully performed. To be most accu-
rate and comparable this process was performed by fol-
lowing the guidelines developed by Beaton et al. as close
as possible [17]. Summarizing the results of the six stages
of cross-cultural adaptation only question 8 caused some
confusion to the forward and back translators and during
the expert committee meeting as well. If someone has no
sport related Achilles tendon pain and scores 0 min of
sports ability, the reason not to train cannot be related to
Achilles tendon pain but may be due to low general fit-
ness. We discussed this point with the authors of the orig-
inal VISA-A questionnaire by E-mail. Besides considering
that different answering modalities have been introduced
to enable pain free patients to score their actual level of
Achilles tendon rehabilitation we were notified that "in
practice" they "haven't had any problems with this"
(Karim Khan personal communication, 2009).
During VISA-A-G questionnaire pretesting we realized
that some subjects got into trouble marking the correct
question 1 answering boxes. Analogue to the VISA-A-S
cross-cultural adaptation [9] we facilitated filling out this
question by inserting the minutes in each respective box
in the final VISA-A-G version.
For the validation and reliability testing we implemented
the methods which were described in the original publica-
tion [8]. Showing significant (p = -0.95 and 0.95) correla-
tions between the VISA-A-G questionnaire and the two
compared classification systems in all tested groups con-
current validity testing of the VISA-A-G questionnaire is
considered to be excellent. Presenting ICC values from
0.60 to 0.97 also the reliability testing was proven to be
"moderate" to "accurate" [21] with respect to each indi-
vidual group of test subjects. It is unclear, why question 6
could not be proven to be sufficiently reliable. VISA-A-G
questionnaire results are not biased by different observers.
This is a result of the self administered and easy to use
nature of the questionnaire. Face validity as assessed by
the observers was good. From our experience with the test-
Relation between VISA-A-G score and Achilles tendon grade of severity by Percy and Conochie [19] Figure 2
Relation between VISA-A-G score and Achilles tendon grade of severity by Percy and Conochie [19]. 1 = excel-
lent (full function and no residual disability); 2 = good (no real limitation of activities); 3 = fair (some limitation of activities); 4 = 
poor (severe weakness and marked limp).
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ing procedure we feel that it can enable also postal explo-
rations.
The authors of the original VISA-A questionnaire empha-
size that it "is not a diagnostic tool" nor does it play a role
in decision making for Achilles tendon surgery [8] and
this statement is true also for the respective translations
including the VISA-A-G questionnaire. Specific local
pathologies (different foot and ankle disorders), central or
peripheral sciatic nerve lesions have to been ruled out as
differential diagnoses before administering one of the
VISA-A questionnaires.
Included pathologies are different from previous work on
this topic. Contrasting to the original VISA-A publication
and to its Swedish translation [8,9] but according to the
Italian translation [12] patients suffering from Haglund's
disease and insertional tendinopathy were excluded. We
believe that these are completely separate pathoanatomic
entities [22] and its inclusion possibly may bias the
results. Therefore the data presented for the validation
and reliability testing of the VISA-A-G questionnaire are
valid only for Achilles tendinopathy. A separate validation
procedure is recommended for Haglund's disease and
insertional Achilles tendinopathy patients. Also different
from the original VISA-A publication [8] and from the
Swedish translation [9] we excluded patients with bilat-
eral Achilles tendon symptoms from participating in the
study as this could possibly confound the answering
behaviour.
The VISA-A questionnaire is a universally accepted instru-
ment. In a Medline search 23 publications were found
entering "VISA-A" in the "all fields" category. Of these
eight were randomized and controlled trials and used the
VISA-A questionnaire (n = 6) or the VISA-A-S (Swedish
version) questionnaire (n = 2). There were two cross-cul-
tural VISA-A adaptations [9,12]. Analyzing the methodo-
logical details, however, five of the randomized controlled
investigations were performed (at least in part) in not
English speaking countries and VISA-A questionnaires
which are not cross-culturally adapted were used
[10,11,13-15]. Even when published in high ranked and
reviewed journals the results obtained from these studies
Relation between VISA-A-G score and the "classification system for the effect of pain on athletic performance" by Curwin and  Stanish [20] Figure 3
Relation between VISA-A-G score and the "classification system for the effect of pain on athletic perform-
ance" by Curwin and Stanish [20]. 1 = no pain and unrestricted level of sports performance; 2 = pain only with extreme 
exertion and unrestricted level of sports performance; 3 = pain with extreme exertion and 1 to 2 hours afterward and normal 
or slightly decreased level of sports performance; 4 = pain during and after any vigorous activities and somewhat decreased 
level of sports performance; 5 = pain during activity forcing termination and markedly decreased level of sports performance; 6 
= pain during daily activities and unable to perform sport.
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are likely biased "as translation does not automatically
provide a valid measure of another culture's health" [17].
The VISA-A score is developing to be the gold standard to
determine the clinical severity of painful Achilles tendon
lesions. Further cross-cultural adapted and validated ver-
sions of the VISA-A questionnaire are needed especially
when international study groups from different language
speaking countries cooperate and compare their results.
The present study explores data on concurrent validity
testing of the VISA-A-G questionnaire and compares the
results in groups of university students, uninjured joggers,
conservatively treated, and preoperative patients with the
published results from the original publication (VISA-A).
Responsiveness including the minimal detectable change
and the minimal clinically important difference have to
be evaluated in future investigations.
Conclusion
The VISA-A questionnaire was successfully cross-cultural
adapted and validated for use in German speaking popu-
lations. The psychometric properties of the VISA-A-G
questionnaire are similar to those of the original English
and the Swedish version. It therefore can be recom-
mended as a sufficiently robust tool for future measuring
clinical severity of Achilles tendinopathy in German
speaking patients.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
HL conceived the study, participated in its design, per-
formed data acquisition, interpreted the data and drafted
the manuscript. TN conceived of the study, participated in
its design, performed data acquisition, analyzed and inter-
preted the data and helped to draft the manuscript. Both
authors read and approved the final manuscript.
Additional material
Acknowledgements
The authors gratefully acknowledge the contribution of Dr. Ackermann, 
Department of Medical Statistics, University Frankfurt for his expert advice 
and Prof. Karim Khan, PhD Karin Grävare Silbernagel, and PhD Dorcas E. 
Beaton for their valuable conceptual E-mail discussions during the cross-
cultural adaptation and validation process of the VISA-A-G questionnaire. 
We further thank Michael Bartelt (forward translation), Michael Shields 
(back translation, Patty Schütze (back translation, expert committee), 
Christiane Riedel (expert committee), and Robin Limmeroth (expert com-
mittee) for their relevant contributions. The article processing charge has 
kindly be accepted by Orthomol pharmazeutische Vertriebs GmbH, Lan-
genfeld, Germany
Additional file 1
Final version of the VISA-A-G questionnaire. translated and cross-cul-
turally adapted VISA-A-G questionnaire.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2474-10-134-S1.doc]
Table 3: Results of reliability testing of the VISA-A-G questionnaire. 
Spearman's rho p ICC p Wilcoxon Cronbach's alpha
Test-Retest Conservative Group (n = 15) 0.66 0.007 0.87 0.000 0.442
Test-Retest Students Group (n = 48) 0.60 0.000 0.97 0.000 0.011
Test-Retest Joggers Group (n = 31) 0.70 0.000 0.60 0.033 0.020
Internal consistency Patients Group (n = 30) 0.74
ICC = Intraclass Correlation Coefficient.
Table 4: Results of reliability testing of the eight VISA-A-G 
items.
Spearman's rho p ICC p Wilcoxon
Question 1 0.58 0.022 0.89 0.000 0.916
Question 2 0.89 0.000 0.89 0.000 0.942
Question 3 0.64 0.009 0.53 0.071 0.088
Question 4 0.65 0.009 0.69 0.022 0.565
Question 5 0.56 0.031 0.65 0.023 0.223
Question 6 0.23 0.411 0.44 0.159 0.681
Question 7 0.69 0.004 0.84 0.001 0.141
Question 8 0.65 0.009 0.75 0.007 0.279
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